Memorial Sloan Kettering Cancer Center 11th Annual Hematology and Medical Oncology Board Review Contemporary Practice 2023
Format: 40 videos + 42 pdf, size: 6.84 GB
Course Audience: oncologist, hematologist
Overview:
Friday, March 10, 2023, 9:00 AM – Monday, March 13, 2023, 1:00 PM, Online, New York, NY
Specialties
This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology. Who Should Attend The target audience for this program is medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents. Live Virtual Format This live virtual program will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). CME credit and ABIM MOC points will be offered for this live virtual program. Detailed access and credit instructions will be emailed to attendees prior to the start of the course. Course registration includes access to an online syllabus, which includes PDFs of the slides and recorded videos of the faculty presentations.
- Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
- Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
- Prepare for ABIM examinations in medical oncology and hematology.
Friday, March 10, 2023
SYLLABUS DISCLAIMER
9:00AM – 9:05AMPlease note only the presentations from faculty that have given their consent will be available below.
Updated on 3/23/23 at 12:00 pm (EST)
MSK CME TERMS OF USE
9:05AM – 9:10AM
Relevant Financial Relationships
9:10AM – 9:15AM
To view faculty disclosures,
Colon Cancer
9:15AM – 10:00AM
Melanoma
10:00AM – 10:45AM
Prostate Cancer
10:45AM – 11:30AM
Kidney Cancer
11:30AM – 12:15PM
Mesothelioma
12:15PM – 12:30PM
Urothelial Cancer
1:15PM – 2:00PM
Testis Cancer
2:00PM – 2:45PM
Uterine/Cervix/Other GYN Cancers
2:45PM – 3:30PM
Ovarian Cancer
3:45PM – 4:30PM
Breast Cancer: Surgery
4:30PM – 5:00PM
Breast Cancer: Radiation Therapy
5:00PM – 5:30PM
Genetics
5:30PM – 6:00PM
Saturday, March 11, 2023
Small Cell Lung Cancer
7:00AM – 7:30AM
Breast Cancer: Adjuvant Therapy
7:30AM – 8:30AM
Breast Cancer: Advanced Disease
8:30AM – 9:30AM
Breast Cancer: Hormonal Therapy
9:30AM – 10:00AM
Carcinoma of Unknown Primary
10:00AM – 10:30AM
Hepatocellular Cancer and Cholangiocarcinoma
10:45AM – 11:30AM
Pancreatic and Neuroendocrine Cancer
11:30AM – 12:15PM
Non Small Cell Lung Cancer
1:00PM – 2:00PM
Head and Neck, Thyroid, Non-melanoma Skin Cancer
2:00PM – 3:00PM
Anal/Rectal Cancer
3:00PM – 3:30PM
Esophageal/Gastric Cancer
3:45PM – 4:30PM
CNS Tumors
4:30PM – 5:00PM
Sarcoma
5:00PM – 5:30PM
Infectious Disease
5:30PM – 6:00PM
Sunday, March 12, 2023
Pharmacology I and II
7:30AM – 9:00AM
CAR T cells
9:10AM – 10:10AM
Low-Grade Non-Hodgkin Lymphoma (NHL)
10:10AM – 10:40AM
Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
10:40AM – 11:10AM
Diffuse Large B-Cell Lymphoma (DLBCL)/Mantle Cell Lymphoma (MCL)/Burkitt Lymohoma (BL)
11:10AM – 12:10PM
Hodgkin Lymphoma (HL)/T Cell
12:40PM – 1:40PM
Auto/Allo
1:40PM – 2:10PM
Acute Lymphoblastic Leukemia (ALL)
2:10PM – 2:40PM
Acute Myeloid Leukemia (AML)
2:40PM – 3:10PM
Myelodysplastic/Myeloprofilerative Neoplasms (MDS/MPN)
3:40PM – 4:40PM
Myeloma/Amyloid
4:40PM – 5:40PM
Monday, March 13, 2023
Approach to The Bleeding Patient
8:05AM – 9:00AM
The Role of the New Direct Oral Anticoagulants in Practice
9:00AM – 10:00AM
Thrombocytopenia, ITP and Beyond
10:00AM – 11:00AM
Sickle Cell Disease, Thalassemia
11:00AM – 12:00PM